Busca avançada
Ano de início
Entree


Immune responses and protection against Streptococcus pneumoniae elicited by recombinant Bordetella pertussis adenylate cyclase (CyaA) carrying fragments of pneumococcal surface protein A, PspA

Texto completo
Autor(es):
Carneiro, Giovanna Brito ; Castro, Julia Tavares ; Davi, Marilyne ; Miyaji, Eliane Namie ; Ladant, Daniel ; Oliveira, Maria Leonor Sarno
Número total de Autores: 6
Tipo de documento: Artigo Científico
Fonte: Vaccine; v. 41, n. 28, p. 13-pg., 2023-06-17.
Resumo

Streptococcus pneumoniae is a common agent of important human diseases such as otitis media, pneumo-nia, meningitis and sepsis. Current available vaccines that target capsular polysaccharides induce protec-tion against invasive disease and nasopharyngeal colonization in children, yet their efficacy is limited to the serotypes included in the formulations. The virulence factor Pneumococcal Surface Protein A (PspA) interacts with host immune system and helps the bacteria to evade phagocytosis. Due to its essential role in virulence, PspA is an important vaccine candidate. Here we have tested a delivery system based on the adenylate cyclase toxin of Bordetella pertussis (CyaA) to induce immune responses against PspA in mice. CyaA was engineered to express fragments of the N-terminal region of PspAs from clades 2 and 4 (A2 and A4) and the resulting proteins were used in immunization experiments in mice. The recombinant CyaA-A2 and CyaA-A4 proteins were able to induce high levels of anti-PspA antibodies that reacted with pneu-mococcal strains expressing either PspA2 or PspA4. Moreover, reactivity of the antibodies against pneu-mococcal strains that express PspAs from clades 3 and 5 (PspA3 and PspA5) was also observed. A formulation containing CyaA-A2 and CyaA-A4 was able to protect mice against invasive pneumococcal challenges with isolates that express PspA2, PspA4 or PspA5. Moreover, a CyaA-A2-A4 fusion protein induced antibodies at similar levels and with similar reactivity as the formulation containing both pro-teins, and protected mice against the invasive challenge. Our results indicate that CyaA-PspA proteins are good candidates to induce broad protection against pneumococcal isolates. & COPY; 2023 Elsevier Ltd. All rights reserved. (AU)

Processo FAPESP: 19/25853-2 - Toxina adenilato ciclase de Bordetella pertussis para a apresentação do antígeno PspA de Streptococcus pneumoniae: caracterização da resposta imune e proteção em camundongos
Beneficiário:Giovanna de Brito Carneiro
Modalidade de apoio: Bolsas no Brasil - Mestrado
Processo FAPESP: 16/13134-3 - Vacinas recombinantes contra Streptococcus pneumoniae e Bordetella pertussis
Beneficiário:Maria Leonor Sarno de Oliveira
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 21/05671-7 - Desenvolvimento de vacinas contra Streptococcus pneumoniae utilizando componentes bacterianos como adjuvantes para o antígeno PspA
Beneficiário:Giovanna de Brito Carneiro
Modalidade de apoio: Bolsas no Brasil - Doutorado Direto
Processo FAPESP: 16/50296-1 - Development of recombinant vaccines against Streptococcus pneumoniae based on the adjuvant activity of the adenylate cyclase toxin from Bordetella pertussis - StrepCyaVac
Beneficiário:Maria Leonor Sarno de Oliveira
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 16/17258-9 - Bordetella pertussis e seus componentes como sistemas de entrega e adjuvantes para o desenvolvimento de vacinas contra Streptococcus pneumoniae
Beneficiário:Júlia Tavares de Castro
Modalidade de apoio: Bolsas no Brasil - Doutorado Direto
Processo FAPESP: 17/01701-3 - Avaliação da toxina adenilato ciclase de Bordetella pertussis como um vetor de entrega para o antígeno PspA de Streptococcus pneumoniae
Beneficiário:Júlia Tavares de Castro
Modalidade de apoio: Bolsas no Exterior - Estágio de Pesquisa - Doutorado Direto